EVEREST I

Enrollment in the EVEREST (Endovascular Valve Edge-to-Edge REpair STudy) I research study was successfully completed in February of 2006.  This FDA approved Phase I study was designed to evaluate the feasibility of the MitraClip® device. For information about the ongoing EVEREST II research study, click here.

Evanston Hospital
Ted Feldman, MD


Columbia University Medical Center
Hal Wasserman , MD

The Cleveland Clinic Foundation
Patrick Whitlow, MD

Hospital of the University of Pennsylvania
Howard C. Herrmann, MD

Swedish Medical Center
William Gray, MD

Emory University
Peter Block , MD

Carolinas Medical Center
Michael J. Rinaldi, MD

Houston Health Sciences Center
Richard Smalling, MD, PhD

Shawnee Mission Medical Center
Paul Kramer, MD

University of Texas Health Sciences Center
Steven R. Bailey, MD

Brigham & Women's Hospital
Andy Eisenhauer, MD

Washington Hospital Center
Kenneth Kent, MD

Return to top.

Within the United States: Investigational Device. Limited by United States law to investigational use. Within Canada: Investigational Device. To Be Used by Qualified Investigators Only – Instrument de recherche. Réservé uniquement à l'usage de chercheurs compétents.

This product is available for commercial distribution in the EU.